Bank of America’s HilleVax HLVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-929
Closed -$1.85K 8485
2025
Q2
$1.85K Sell
929
-183,732
-99% -$336K ﹤0.01% 7443
2025
Q1
$268K Sell
184,661
-47,269
-20% -$87.4K ﹤0.01% 6015
2024
Q4
$480K Buy
231,930
+78,739
+51% +$148K ﹤0.01% 5569
2024
Q3
$270K Buy
153,191
+112,033
+272% +$287K ﹤0.01% 5869
2024
Q2
$595K Buy
41,158
+13,148
+47% +$181K ﹤0.01% 5240
2024
Q1
$466K Sell
28,010
-18,191
-39% -$291K ﹤0.01% 5397
2023
Q4
$742K Buy
46,201
+17,381
+60% +$231K ﹤0.01% 5216
2023
Q3
$388K Buy
28,820
+10,430
+57% +$147K ﹤0.01% 5492
2023
Q2
$316K Buy
18,390
+4,650
+34% +$72.1K ﹤0.01% 5553
2023
Q1
$227K Sell
13,740
-8,752
-39% -$140K ﹤0.01% 5856
2022
Q4
$376K Buy
22,492
+18,942
+534% +$342K ﹤0.01% 5573
2022
Q3
$60K Sell
3,550
-365
-9% -$5.31K ﹤0.01% 6593
2022
Q2
$43K Buy
+3,915
New +$46.5K ﹤0.01% 6907

Bank of America's HLVX Position: Q3 2025 in Review

Bank of America sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 929 shares — an estimated $1.85K sold.

Bank of America first reported a position in HLVX in Q2 2022 and held it in 13 quarters. The position peaked at $742K in Q4 2023. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

  • Bank of America reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
  • Bank of America sold 929 HilleVax shares in Q3 2025, an estimated $1.85K.
  • Bank of America first reported a position in HilleVax in Q2 2022 and held it in 13 quarters.
  • Bank of America's HilleVax position peaked at $742K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Bank of America's 13F filing for Q3 2025, filed 14 Nov 2025.